The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | L | Antineoplastic and immunomodulating agents | |
| 2 | L02 | Endocrine therapy | |
| 3 | L02A | Hormones and related agents | |
| 4 | L02AE | Gonadotropin releasing hormone analogues | |
| 5 | L02AE02 | Leuprorelin |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| PAREN - Parenteral | 1 mg |
| PAREN - Parenteral (depot) | 134 mg |
| SC - Subcutaneous (implant) | 60 ug |
| Active Ingredient | Description | |
|---|---|---|
| Leuprorelin |
Leuprorelin is inactive when given orally due to poor membrane permeability and an almost complete inactivation by intestinal proteolytic enzymes. Leuprorelin has potent LHRH agonist properties when given during short-term and intermittent therapy, however, when administered in a continuous, nonpulsatile manner, LHRH analogs induce inhibition of gonadotropin secretion and suppression of testicular steroidogenesis. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CAMCEVI Prolonged-release suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| LECTRUM Powder for suspension for injection | Marketing Authorisation Holder | MPI, EU: SmPC | |
| LUCRIN Depot Solution for injection | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| LUPRON DEPOT Powder for solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| LUTRATE DEPOT Powder and solvent for prolonged-release suspension for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| PROSTAP 3 DCS Powder and solvent for suspension for injection in pre-filled syringe | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
